Poland· PL-100092482
Trifas 20
A torasemide product containing torasemidum, registered in Poland by Menarini International Operations Luxembourg S.A.. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Torasemide is registered in 12 of 19 countries.
Countries holding a registration under ATC C03CA04 (torasemide), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Torasemide · ATC C03CA04
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Germany
- Ireland
- Italyprice
- Japan
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of torasemide costs, country by country.
Normalised to the WHO defined daily dose (15 mg), the median price runs from $0.28 in Italy to $0.58 in Switzerland — a ×2.1 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Torasemide · price per daily dose (15 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.58
- ES Spain$0.30
- IT Italy$0.28
The record
At a glance
URPL (Poland)- Active substance
- Torasemidum
- Manufacturer
- Menarini International Operations Luxembourg S.A.
- Country
- Poland (PL)
- ATC code
- C03CA04
- ATC class
- Torasemide
- Defined daily dose
- 15 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990471614
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
339 interactions on record for torasemide.
Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Torasemide · interactions on record
339 records
- 15 severe
- 214 moderate
- 10 minor
- 97 info
Most severe, free to view
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Torasemide in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesSOAANZSarfez Pharmaceuticals Inc
- SwitzerlandTorasemid Mylan 10 mg, TablettenViatris Pharma GmbH
- SpainDILUTOL 10 mg COMPRIMIDOSViatris Healthcare Limited
- United KingdomTorasemide 10mg tabletsTeva UK Ltd
- GermanyTorasemid 1 A Pharma1 A Pharma Gmbh
- CzechiaGROLANMenarini International Operations Luxembourg S.A., Luxembourg
- SwedenTorasemid Ebb 10 mg TablettEbb Medical AB
- ItalyDIUREMIDMENARINI INTERNAT. O.L.S.A
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Torasemid Hexal
- Belgium · Torasemide Sandoz, Torrem
- Bulgaria · Toraflora, Диурестад
- Cyprus · Guperul
- Czechia · Torasemid Stada
- Germany · Torasemid 1 A Pharma, Torasemid Aaa
- Estonia · Torasemide, Torasemide Auxilia
- Spain · Dilutol, Dilutol Hta
- United Kingdom (Northern Ireland) · Torasemide, Torasemide Medreich
- Greece · Rosadim, Toresix
- Croatia · Diuver, Tomid
- Hungary · Tretax
- Ireland · Torasemide Azure Pharmaceuticals
- Italy · Diuremid, Diuresix
- Lithuania · Torasemide Auxilia, Torasemide Hexal
- Luxembourg · Torasemid Micro Labs, Torrem
- Latvia · Torasemide Hexal, Torasemide Polfarmex
- Sweden · Torasemid Zentiva, Torem
- Slovenia · Diuver
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f2c7bedb-a394-44c9-8e51-de11940338f7 GET /v1/drugs/f2c7bedb-a394-44c9-8e51-de11940338f7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "5 mg/ml",
"packaging": "05909990471614 ¦ Rp ¦ 15136\n5 amp. 4 ml",
"substance": "Torasemidum 20 mg",
"common_name": "Torasemidum",
"pl_product_id": "100092482",
"pozwolenie_nr": "04716",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about torasemide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.